John Strahley

Form D signer

John Strahley

Chief Financial Officer at Aspira Women's Health

Form D signer

Capital raised by Aspira Women's Health

$5.8M+$1.5M latest round

3 Form D filings · first filed Mar 2025 · Austin, TX

CURRENT ROLE: Chief Financial Officer
SECTOR: Biotech
COMPANY FILINGS: 3
TEAM ON FILE: 4
FOUNDED: —
30D INTEREST: 4 ↗

Career

1 company on file

Aspira Women's HealthBiotech · Austin, TXsince Mar 2025

Chief Financial Officer

Signatory on Aspira Women's Health's Form D filings · $5.8M raised across 3

Company filings

via EDGAR · Form D for Aspira Women's Health3

DateCompanyFormAmountRole on filing

Jun 5, 2026Aspira Women's HealthForm D+$1.5MChief Financial Officer

Form DJun 5, 2026 · Aspira Women's Health+$1.5Mas Chief Financial Officer

Sep 16, 2025Aspira Women's HealthForm D+$3.0MChief Financial Officer

Form DSep 16, 2025 · Aspira Women's Health+$3.0Mas Chief Financial Officer

Mar 5, 2025Aspira Women's HealthForm D+$1.4MChief Financial Officer

Form DMar 5, 2025 · Aspira Women's Health+$1.4Mas Chief Financial Officer

Overview

Last filing Jun 5, 2026

John Strahley is on file as Chief Financial Officer at Aspira Women's Health in Austin, TX. Aspira Women's Health has 3 Form D filings on record, $5.8M raised in total. John Strahley appears as a signatory on the company's filings.

Teammates

Aspira Women's Health · 3

Ellen BeausangDirector Michael BuhleChief Executive OfficerSigner Winfred ParnellDirector

Products

Aspira Women's Health · 1

OvaSuiteDiagnostic Blood Tests

OvaSuite is a comprehensive suite of blood tests designed to aid in the assessment of ovarian cancer risk. It includes specific tests tailored to monitor and evaluate the presence of malignancy in adnexal masses.